Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015

Abstract Background Ventilator-associated pneumonia (VAP) is a common nosocomial infection in intensive care units (ICUs). The objective of this study was to describe the epidemiology and microbiology of VAP in Polish ICUs from 2013 to 2015, as well as to understand how these depended on the diagnos...

Full description

Bibliographic Details
Main Authors: Michał Wałaszek, Anna Różańska, Marta Zofia Wałaszek, Jadwiga Wójkowska-Mach, The Polish Society of Hospital Infections Team
Format: Article
Language:English
Published: BMC 2018-07-01
Series:BMC Infectious Diseases
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12879-018-3212-8
_version_ 1819022857261285376
author Michał Wałaszek
Anna Różańska
Marta Zofia Wałaszek
Jadwiga Wójkowska-Mach
The Polish Society of Hospital Infections Team
author_facet Michał Wałaszek
Anna Różańska
Marta Zofia Wałaszek
Jadwiga Wójkowska-Mach
The Polish Society of Hospital Infections Team
author_sort Michał Wałaszek
collection DOAJ
description Abstract Background Ventilator-associated pneumonia (VAP) is a common nosocomial infection in intensive care units (ICUs). The objective of this study was to describe the epidemiology and microbiology of VAP in Polish ICUs from 2013 to 2015, as well as to understand how these depended on the diagnostic methods used to identify VAP pathogens and the clinical strategy for VAP treatment. Methods This observational study was carried out in seven Polish adult ICUs. VAP surveillance was based on the European Healthcare-associated Infections Surveillance Network recommendations and was defined as pneumonia occurring more than 48 h after receiving mechanical ventilation, with symptom onset 3 days or more after the hospital stay. Depending on the microbiological diagnostic method, VAP cases were classified as PNEU-1 (positive quantitative culture from minimally contaminated lower respiratory tract specimen such as broncho-alveolar lavage, protected brush or distal protected aspirate) or other VAP cases. Results The incidence of VAP was 8.0% and the incidence density: 12.3/1000 ventilator days. Microbiological diagnosis was made using PNEU-1 in 80 cases (39%); over the study duration, the proportion of cases diagnosed with PNEU-1 increased from 14 to 60% (p < 0.001). The predominant etiologic agents causing VAP were Enterobacteriaceae (32.6%) and non-fermenting Gram-negative bacteria (27.6%). The causative microbe varied significantly depending on the diagnostic method: in cases diagnosed using PNEU-1, Staphylococcus aureus (21.3%) and Klebsiella pneumoniae (12.5%) were the dominant organisms, whereas in other VAP cases, Acinetobacter baumannii (23.8%) was commonly observed. The length of antibiotic treatment in cases diagnosed with PNEU-1 was shorter than for other VAP cases (7.2 vs. 9.1 days, p < 0.005), as was the duration of hospitalization (49 vs. 51.8 days, p < 0.001). Antibiotic resistance was a particular concern for A.baumannii isolates, which were highly resistance to imipenem (70.6%) and meropenem or doripenem (52.9%). K. pneumoniae isolates demonstrated resistance to ampicillin (90.3%), ceftazidime (71.0%) and third-generation cephalosporins (74.2%). Conclusion A change over time was observed in the microbiological diagnostic methods used for patients with VAP. A. baumannii was observed mainly in VAP cases diagnosed using substandard methods (non-PNEU-1). The duration of treatment for VAP patients diagnosed properly using PNEU-1 was shorter.
first_indexed 2024-12-21T04:29:39Z
format Article
id doaj.art-3eaff3810c8c4242b040a753f1134fbd
institution Directory Open Access Journal
issn 1471-2334
language English
last_indexed 2024-12-21T04:29:39Z
publishDate 2018-07-01
publisher BMC
record_format Article
series BMC Infectious Diseases
spelling doaj.art-3eaff3810c8c4242b040a753f1134fbd2022-12-21T19:15:58ZengBMCBMC Infectious Diseases1471-23342018-07-011811910.1186/s12879-018-3212-8Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015Michał Wałaszek0Anna Różańska1Marta Zofia Wałaszek2Jadwiga Wójkowska-Mach3The Polish Society of Hospital Infections TeamPolish Society of Hospital InfectionsDepartment of Microbiology, Jagiellonian University Collegium MedicumState Higher Vocational School in TarnówDepartment of Microbiology, Jagiellonian University Collegium MedicumAbstract Background Ventilator-associated pneumonia (VAP) is a common nosocomial infection in intensive care units (ICUs). The objective of this study was to describe the epidemiology and microbiology of VAP in Polish ICUs from 2013 to 2015, as well as to understand how these depended on the diagnostic methods used to identify VAP pathogens and the clinical strategy for VAP treatment. Methods This observational study was carried out in seven Polish adult ICUs. VAP surveillance was based on the European Healthcare-associated Infections Surveillance Network recommendations and was defined as pneumonia occurring more than 48 h after receiving mechanical ventilation, with symptom onset 3 days or more after the hospital stay. Depending on the microbiological diagnostic method, VAP cases were classified as PNEU-1 (positive quantitative culture from minimally contaminated lower respiratory tract specimen such as broncho-alveolar lavage, protected brush or distal protected aspirate) or other VAP cases. Results The incidence of VAP was 8.0% and the incidence density: 12.3/1000 ventilator days. Microbiological diagnosis was made using PNEU-1 in 80 cases (39%); over the study duration, the proportion of cases diagnosed with PNEU-1 increased from 14 to 60% (p < 0.001). The predominant etiologic agents causing VAP were Enterobacteriaceae (32.6%) and non-fermenting Gram-negative bacteria (27.6%). The causative microbe varied significantly depending on the diagnostic method: in cases diagnosed using PNEU-1, Staphylococcus aureus (21.3%) and Klebsiella pneumoniae (12.5%) were the dominant organisms, whereas in other VAP cases, Acinetobacter baumannii (23.8%) was commonly observed. The length of antibiotic treatment in cases diagnosed with PNEU-1 was shorter than for other VAP cases (7.2 vs. 9.1 days, p < 0.005), as was the duration of hospitalization (49 vs. 51.8 days, p < 0.001). Antibiotic resistance was a particular concern for A.baumannii isolates, which were highly resistance to imipenem (70.6%) and meropenem or doripenem (52.9%). K. pneumoniae isolates demonstrated resistance to ampicillin (90.3%), ceftazidime (71.0%) and third-generation cephalosporins (74.2%). Conclusion A change over time was observed in the microbiological diagnostic methods used for patients with VAP. A. baumannii was observed mainly in VAP cases diagnosed using substandard methods (non-PNEU-1). The duration of treatment for VAP patients diagnosed properly using PNEU-1 was shorter.http://link.springer.com/article/10.1186/s12879-018-3212-8Ventilator-associated pneumonia (VAP)Healthcare-associated infections (HAI)Intensive care unit (ICU)PolandAcinetobacter baumannii
spellingShingle Michał Wałaszek
Anna Różańska
Marta Zofia Wałaszek
Jadwiga Wójkowska-Mach
The Polish Society of Hospital Infections Team
Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015
BMC Infectious Diseases
Ventilator-associated pneumonia (VAP)
Healthcare-associated infections (HAI)
Intensive care unit (ICU)
Poland
Acinetobacter baumannii
title Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015
title_full Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015
title_fullStr Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015
title_full_unstemmed Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015
title_short Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015
title_sort epidemiology of ventilator associated pneumonia microbiological diagnostics and the length of antimicrobial treatment in the polish intensive care units in the years 2013 2015
topic Ventilator-associated pneumonia (VAP)
Healthcare-associated infections (HAI)
Intensive care unit (ICU)
Poland
Acinetobacter baumannii
url http://link.springer.com/article/10.1186/s12879-018-3212-8
work_keys_str_mv AT michałwałaszek epidemiologyofventilatorassociatedpneumoniamicrobiologicaldiagnosticsandthelengthofantimicrobialtreatmentinthepolishintensivecareunitsintheyears20132015
AT annarozanska epidemiologyofventilatorassociatedpneumoniamicrobiologicaldiagnosticsandthelengthofantimicrobialtreatmentinthepolishintensivecareunitsintheyears20132015
AT martazofiawałaszek epidemiologyofventilatorassociatedpneumoniamicrobiologicaldiagnosticsandthelengthofantimicrobialtreatmentinthepolishintensivecareunitsintheyears20132015
AT jadwigawojkowskamach epidemiologyofventilatorassociatedpneumoniamicrobiologicaldiagnosticsandthelengthofantimicrobialtreatmentinthepolishintensivecareunitsintheyears20132015
AT thepolishsocietyofhospitalinfectionsteam epidemiologyofventilatorassociatedpneumoniamicrobiologicaldiagnosticsandthelengthofantimicrobialtreatmentinthepolishintensivecareunitsintheyears20132015